Viewing Study NCT01297595


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2025-12-29 @ 1:11 PM
Study NCT ID: NCT01297595
Status: COMPLETED
Last Update Posted: 2012-02-16
First Post: 2011-02-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A8081019
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators